Skip to content
DraconiticResearch
Search Sources API
211,646 studies31 sourcesUpdated 15 min ago

Oncology

5,331 studies510 in 7 days2,567 in 30 days

Filters
Type
Date
Clear

Latest

5,331 studies

  1. The Rationale for Tissue Biopsy in the Era of Precision Hepatocellular Carcinoma Management
    Ioanna-Maria Grypari, Dina G. Tiniakos, Maria Kalafateli +1
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  2. Digital 3D Technology in Pediatric Surgical Oncology: An Expert White Paper
    Nick de Groot, Pamela Lustig, Sadie Lynn Love +7
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  3. Statistical models to characterize colon tumor stiffness heterogeneity through representative atomic force microscopy maps
    Gauthier Gadouas, Guillaume Tosato, Luca Costa +7
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyHAL
  4. Association between adjuvant EGFR-TKI therapy and survival outcomes in completely resected stage I invasive lung adenocarcinoma (≤3 cm) with sensitizing EGFR mutations and pathological high-risk features.
    Jie Cao, Zhaokang Huang, Fang Qiu +9
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  5. Comprehensive needs among patients with gastrointestinal cancer receiving chemotherapy: A cross-sectional latent profile analysis.
    Hui Shan, Hongyan Zhang, Nannan Song +3
    Asia-Pacific journal of oncology nursingPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  6. Associations between interoceptive awareness and symptom clusters in patients with lung cancer undergoing chemotherapy: A joint network analysis
    Xingliang Zhang, Xueru Chen, Xinyu Wu +3
    Asia-Pacific Journal of Oncology NursingPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  7. Endocrine therapy adherence and 10-year cardiometabolic risk in hormone receptor-positive breast cancer
    Jorge R Ledesma, Joshua Nugent, Richard Cheng +9
    JNCI Cancer SpectrumPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  8. FluxAtlas is a pan-cancer metabolic flux atlas that identifies tumor-selective dependencies and prognostic biomarkers
    Manas Kohli, Aurélien Tripp, Anastasiia Shcherbakova +1
    Cell ReportsPeer-reviewedCC BY 4.0Full textOncologyPMC
  9. Phylogenetic and phylodynamic approaches to understanding the evolution of non-small cell lung cancer using single-cell sequencing
    Teng Li, Xianghan Li, Yiran Zou +5
    OncogenePeer-reviewedCC BY 4.0Full textOncologyPMC
  10. Interleukin-17A directly triggers Epstein-Barr virus lytic reactivation in latency I human B-cell models
    Janardhan Avilala, Hirotomo Dochi, Ramsy Abdelghani +8
    Journal of VirologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  11. Efficacy and biomarker analysis for nivolumab in cancer of unknown primary: results from an investigator-initiated expanded access program
    Junko Tanizaki, Kan Yonemori, Yuichi Takiguchi +19
    International Journal of Clinical OncologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  12. Glutamine and GLS1 are key metabolic checkpoints that Limit T cell Infiltration and Function in HNSCC
    S. M. Decking-Paede, I. Ugele, K. Dettmer +38
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  13. Mutation Order and Selection Shape Intratumor Heterogeneity in Tumor Evolution
    Y. Chu, X. Sheng, X. Zhang +1
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  14. Spatial analysis of canine glioma reveals heterogeneous intratumoral niches characterized by distinct patterns of cell plasticity and immunosuppression
    S. R. Nelissen, A. Stephanou, E. N. Glass +6
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  15. m6A-Driven Intratumoral Cholesterol Biosynthesis Fuels Castration-Resistant Prostate Cancer Progression
    J. H. Lee, Z. Zhang, J. Hong +15
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  16. Spatial immune profiling reveals lymphocyte confinement to myeloid-mesenchymal niches and heterogeneous therapeutic T-cell opportunity in pediatric ependymoma
    P. Truong, R. Mirzazadeh, J. Lundeberg +2
    bioRxivPreprintCC BYFull textOncologybioRxiv
  17. ST6Gal2 promotes α2,6-sialylation and aggressive phenotypes in neuroblastoma cells
    L. Swami, P. Mandadapu, M. E. Lopez +5
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  18. Unsupervised transcriptomic analysis of paired pre- and post-treatment specimens reveals divergent chemoimmunomodulatory induction trajectories in breast cancer
    I. Lopes de Lima, E. Molchan, K. H. Streeks +4
    bioRxivPreprintCC BYFull textOncologybioRxiv
  19. Combined Loss of VHL and TSC1 Drives Clear Cell Renal Cell Carcinoma with Metabolic and Redox Reprogramming that Creates an NRF2 Dependency
    J. Xu, X. Cheng, O. A. Aboud +8
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  20. Context-specific genetic interaction mapping reveals combinatorial KRAS/FGFR dependence in pancreatic cancer
    R. Y. Ebright, Y. He, A. G. Zhang +21
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  21. ALDH1B1 promotes mitochondrial γ-butyrobetaine biosynthesisand fatty acid oxidation in colorectal cancer
    Z. Feng, T. E. Bearrood, S. L. Campbell +10
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  22. Discovery of Covalent Wild-Type Isocitrate Dehydrogenase 1 (IDH1) Inhibitors Targeting Cys269
    C. P. Brown, E. O. Harmer, A. Azam +5
    bioRxivPreprintCC BYFull textOncologybioRxiv
  23. Disrupting aberrant EGFR catalytic trimers reverses T790M gefitinib resistance
    S. K. Roberts, I. Galdadas, N. Piasentin +10
    bioRxivPreprintCC BYFull textOncologybioRxiv
  24. Age and Sex Influence the Neutrophil-to-Lymphocyte Ratio (NLR), a Systemic Inflammation Marker.
    Carmen Lara-Apolinario, Cesar Martinez-Carral, Desiree Fischetti +3
    Clinics and practicePeer-reviewedCC BYFull textOncologyEurope PMC
  25. Confirmed Myocarditis-Myositis Overlap Without Myasthenia Gravis: Evaluating for Triple M Syndrome Following Combined Enfortumab Vedotin and Pembrolizumab Therapy.
    Bryan Ashong, Yash Ranga
    CureusPeer-reviewedCC BYFull textOncologyEurope PMC